Records containing: NASH - Nonalcoholic Steatohepatitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-01-13Characterization of the Platelet Inflammatory Response in NAFL and NASH
-
CLINICAL_TRIALS study record update · 2021-10-11A Phase I Single Dose Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects.
-
CLINICAL_TRIALS study record update · 2021-09-27Curcumin for Pediatric Nonalcoholic Fatty Liver Disease: A Pilot Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-09-08The Effects of Plant Sterol and Plant Stanol Ester Enriched Foods on Liver Inflammation in Subjects at Risk to Develop NASH
-
CLINICAL_TRIALS study record update · 2021-08-16A Double-blind, Sponsor-Open, Placebo-controlled, Phase I Study of the Safety, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of HU6 in High BMI Volunteers
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-07-15The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology
-
CLINICAL_TRIALS study record update · 2021-07-12MMONARCh-1: Study of MSDC-0602K, a Modulator of the Mitochondrial Pyruvate Carrier for Outcomes in Patients With Pre Type 2 Diabetes (T2D) or T2D and NAFLD/NASH, Assessed for ImpRoved Glycemic Control and Cardiovascular Outcomes-1
-
CLINICAL_TRIALS study record update · 2021-07-12The Liver in the World Trade Center Health Program General Responder Cohort and Controls
-
CLINICAL_TRIALS study record update · 2021-06-14Identification of Clinical and Biological Factors Determining Disease Severity and Disease Progression in NAFLD: "THE FRENCH NATIONAL NAFLD COHORT" FRAMES (FRench pAtients With MEtabolic Steatosis)
-
CLINICAL_TRIALS study record update · 2021-06-04A Phase 1a, Double Blind, Placebo-Controlled, Single-Center, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2021-06-01A Phase 2A Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2021-05-19Liquid Biopsy as a Non-invasive Tool for the Diagnosis of NASH and Liver Fibrosis
-
CLINICAL_TRIALS study record update · 2021-05-18Prevalence of NASH in Subjects With Different Classes of Obesity
-
CLINICAL_TRIALS study record update · 2021-05-04A Double-blind, Placebo-controlled, Phase I Study of the Safety and Pharmacokinetics of Single Ascending Doses of HU6 in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2021-03-30Intragastric Balloon in Combination With Lifestyle Intervention vs. Lifestyle Intervention Alone in Obese Patients Having NASH With Significant Fibrosis
-
CLINICAL_TRIALS study record update · 2021-03-05The Effects of Plant Stanol Ester Supplements on Liver Inflammation in Overweight and Obese Children
-
CLINICAL_TRIALS study record update · 2021-02-25Evaluation of Duodenal Mucosal Resurfacing (DMR) for the Treatment of Non Alcoholic Steatohepatitis (NASH), a Proof of Concept Study
-
CLINICAL_TRIALS study record update · 2021-02-03Development and Evaluation of the Effectiveness of Complex Therapy of Steatohepatitis of Various Aetiologies Based on Metabolomic Analysis With the Use of Innovative Medical Nutrition Products
-
CLINICAL_TRIALS study record update · 2021-02-02A Multicenter, Controlled Study to Evaluate the Efficacy and Safety of an Endoscopic Sutured Gastroplasty (With Endomina Device) in Patients With Non Alcoholic Steatohepatitis (NASH) and Fibrosis.
-
CLINICAL_TRIALS study record update · 2020-10-14Multicenter, Open-label, Safety and Tolerability Study of Ascending Doses of HepaStem in Patients With Cirrhotic and Pre-cirrhotic Non-alcoholic Steato-hepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2020-09-25A Phase 1b, Open-label Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FXR Agonist/Modulator EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis Patients
-
CLINICAL_TRIALS study record update · 2020-09-24Genetic Variations in Adipokine to Improve Risk Prediction for NAFLD and Its Progression to NASH in Egyptian Patients
-
CLINICAL_TRIALS study record update · 2020-09-04Companion Protocol for the ¹³C-Methacetin Breath Test Using the BreathID® MCS System for Conatus Phase 2 Study of Emricasan, an Oral Caspase Inhibitor, Under Protocol IDN-6556-14 (NCT02960204)
-
CLINICAL_TRIALS study record update · 2020-09-01Mechanism of DCs Dysfunction in Chronic HBV Infection
-
CLINICAL_TRIALS study record update · 2020-08-21A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)